PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Alexa Fluor® 594 anti-TAL1, 100 μg
Alexa Fluor® 594 anti-TARP γ2 (Stargazin) , 100 μg
Alexa Fluor® 594 anti-TFIIB, 100 μg
Alexa Fluor® 594 anti-TOX, 100 μg
Alexa Fluor® 594 anti-Tubulin Beta 3 (TUBB3), 100 μg
Alexa Fluor® 594 anti-Tubulin-α, 100 μg
Alexa Fluor® 594 anti-Vimentin, 100 μg
Alexa Fluor® 594 anti-β-actin, 100 μg
Alexa Fluor® 647 Annexin V, 100 tests
Alexa Fluor® 647 Annexin V, 25 tests
Alexa Fluor® 647 Annexin V, 300 tests
Alexa Fluor® 647 anti-Acetylated Lysine, 100 tests
Alexa Fluor® 647 anti-Acetylated Lysine, 25 tests
Alexa Fluor® 647 anti-Bcl-2, 100 tests
Alexa Fluor® 647 anti-Bcl-2, 100 μg
Alexa Fluor® 647 anti-Bcl-2, 25 tests